Orient EuroPharma Co., Ltd.

Industry

  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Nutraceuticals
    • Generic Drugs
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products

Other Names/Subsidiaries

  • Cyntec Co. Ltd.
  • OrientPHARMA Co., Ltd. (OP)
See more in Biomedtracker

Latest on Orient EuroPharma Co., Ltd.

Scrip

Asia Deal Watch: JCR And Alexion Build Upon Existing Gene Therapy Alliances

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. JCR Adds $825m Gene Therapy Tech D

Scrip

Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. JCR Signs Deal With Sumitomo On Izcargo

Scrip

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

 
• By Joseph Haas and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis

Scrip

Asia Deal Watch: Bone Therapeutics Licenses Bone Cell Therapy Tech To Two Asian Firms

 
• By Ian Haydock, Brian Yang, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bone Links With Two Chinese Firms For A